Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$15,378
-$17,720 QoQ
Shares Held
214
-23.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,215
of 1,408 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $193,049 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,734 | $75,175 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
67 | $36,302 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
103 | $17,359 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
680 | $16,734 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
214 | $15,378 | |
| 6 | ALKS |
Alkermes plc.
|
159 | $8,331 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
65 | $7,211 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
260 | $4,500 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,378 | 214 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $33,098 | 280 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $41,394 | 329 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $147,490 | 1,008 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $182,929 | 1,173 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $180,950 | 1,099 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $198,122 | 1,216 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $239,340 | 1,225 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $206,471 | 1,191 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $177,501 | 1,049 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $206,449 | 1,046 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $245,833 | 1,413 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $239,544 | 1,391 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $230,020 | 1,382 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $136,731 | 933 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $213,389 | 1,439 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $212,971 | 1,239 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $228,005 | 1,209 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $301,133 | 1,234 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $45,622 | 235 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $225,309 | 1,209 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $90,551 | 575 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $38,892 | 235 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $38,861 | 235 | Shares | Sole | 2020-10-27 | |
| No filing history on record for this holder in this stock. | ||||||